Translational Pathways for Cardiovascular Devices – Session IV: Methods for Coronary Stent Development – Chuck Simonton Practice Quiz
Quiz Summary
0 of 6 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
You have completed the practice quiz, please continue on to the next session.
- 1
- 2
- 3
- 4
- 5
- 6
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 6
1. Question
Which of the following is the mechanism of Everolimus on reducing cell proliferation?
CorrectIncorrect - Question 2 of 6
2. Question
Pharmacokinetics and degradation profile of a drug-eluting stent should guide the selection of time points for efficacy assessment in the animal model?
CorrectIncorrect - Question 3 of 6
3. Question
Which of the following recommended evaluation time points for drug-eluting stents in the animal is correct?
CorrectIncorrect - Question 4 of 6
4. Question
Drug eluting stents in the US are regulated by and classified as:
CorrectIncorrect - Question 5 of 6
5. Question
Regulatory classification of drug-eluting stents are?
CorrectIncorrect - Question 6 of 6
6. Question
Long term outcomes of stenting include which of the following?
CorrectIncorrect